Balancing Weight Loss and Sarcopenia in Elderly Patients With Peripheral Artery Disease

Damianos G Kokkinidis, Ehrin J Armstrong, Jay Giri, Damianos G Kokkinidis, Ehrin J Armstrong, Jay Giri

Abstract

See Article Polonsky et al.

Keywords: Editorials; exercise; obesity; peripheral artery disease.

References

    1. Hirsch AT, Criqui MH, Treat‐Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324.
    1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WRC, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LMJ, White CJ, White J, White RA, Antman EM, Smith SCJ, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter‐Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47:1239–1312.
    1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386.
    1. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257–1264.
    1. Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, Criqui MH. Ethnic‐specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32:328–333.
    1. de Liefde II, Hoeks SE, van Gestel YRBM, Klein J, Bax JJ, Verhagen HJM, van Domburg RT, Poldermans D. The prognostic value of impaired walking distance on long‐term outcome in patients with known or suspected peripheral arterial disease. Eur J Vasc Endovasc Surg. 2009;38:482–487.
    1. Nehler MR, McDermott MM, Treat‐Jacobson D, Chetter I, Regensteiner JG. Functional outcomes and quality of life in peripheral arterial disease: current status. Vasc Med. 2003;8:115–126.
    1. Polonsky TS, Tian L, Zhang D, Bazzano LA, Criqui MH, Ferrucci L, Guralnik JM, Kibbe MR, Leeuwenburgh C, Sufit RL, McDermott MM. Associations of weight change with changes in calf muscle characteristics and functional decline in peripheral artery disease. J Am Heart Assoc. 2019;8:e010890 DOI: 10.1161/JAHA.118.010890.
    1. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai PJ, Razak F, Sharma AM, Anand SS. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case‐control study. Lancet. 2005;366:1640–1649.
    1. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–763.
    1. Woo J, Yu R, Wong M, Yeung F, Wong M, Lum C. Frailty screening in the community using the FRAIL scale. J Am Med Dir Assoc. 2015;16:412–419.
    1. Reijnierse EM, Trappenburg MC, Blauw GJ, Verlaan S, de van der Schueren MAE, Meskers CGM, Maier AB. Common ground? The concordance of sarcopenia and frailty definitions. J Am Med Dir Assoc. 2016;17:371.e7–12.
    1. Yoshimura Y, Uchida K, Jeong S, Yamaga M. Effects of nutritional supplements on muscle mass and activities of daily living in elderly rehabilitation patients with decreased muscle mass: a randomized controlled trial. J Nutr Health Aging. 2016;20:185–191.
    1. Fougere B, Vellas B, van Kan GA, Cesari M. Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia. Transl Neurosci. 2015;6:103–110.
    1. Martin GP, Sperrin M, Ludman PF, de Belder MA, Redwood SR, Townend JN, Gunning M, Moat NE, Banning AP, Buchan I, Mamas MA. Novel United Kingdom prognostic model for 30‐day mortality following transcatheter aortic valve implantation. Heart. 2018;104:1109–1116.
    1. Shea MK, Houston DK, Nicklas BJ, Messier SP, Davis CC, Miller ME, Harris TB, Kitzman DW, Kennedy K, Kritchevsky SB. The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT Study. J Gerontol A Biol Sci Med Sci. 2010;65:519–525.
    1. Shea MK, Nicklas BJ, Houston DK, Miller ME, Davis CC, Kitzman DW, Espeland MA, Appel LJ, Kritchevsky SB. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. Am J Clin Nutr. 2011;94:839–846.
    1. Li Z, Heber D. Sarcopenic obesity in the elderly and strategies for weight management. Nutr Rev. 2012;70:57–64.
    1. Armstrong EJ, Alam S, Henao S, Lee AC, DeRubertis BG, Montero‐Baker M, Mena C, Cua B, Palena LM, Kovach R, Chandra V, AlMahameed A, Walker CM. Multidisciplinary care for critical limb ischemia: current gaps and opportunities for improvement. J Endovasc Ther. 2019;26:199–212.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel